A recent study observed that circ_0011292 facilitated tumorigenesis and paclitaxel resistance in NSCLC by regulating the miR-379-5p/TRIM65 axis, suggesting circ_0011292 was a promising therapeutic target for NSCLC chemotherapy (242). The gene discussed is TRIM65; the disease is non-small cell lung carcinoma.